Clinical phase II study and pharmacological evaluation of rubitecan in non-pretreated patients with metastatic colorectal cancer-significant effect of food intake on the bioavailability of the oral camptothecin analogue.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples